Autres langues Eurofins Scientific SE

Actions

ERF

FR0014000MR3

Recherche biotechnologique et médicale

Marché Fermé - Euronext Paris 17:55:00 18/08/2026			Après clôture 21:40:46
69,66 ^EUR	-0,49%		69,82	+0,23%

03/08	Avis d'analystes du jour : Stellantis toujours sous pression, KBW revalorise les banques françaises
03/08	Tout est sous contrôle ?

Autres langues

17:46	Eurofins Scientific SE: Weekly Report on Share Repurchases from 10th August to 14th August 2026
14/08	Eurofins Scientific: Director/PDMR Shareholding
13/08	Eurofins CDMO Alphora Expands Kilolab and High Potency Development and Manufacturing Capabilities
12/08	Eurofins Scientific: Director/PDMR Shareholding
10/08	Eurofins Scientific SE: Weekly Report on Share Repurchases from 03rd August to 07th August 2026
07/08	Eurofins Scientific: Director/PDMR Shareholding
04/08	Eurofins Scientific: Director/PDMR Shareholding
03/08	Eurofins: Weekly Report on Share Repurchases From 27th July to 31st July 2026
03/08	Eurofins Scientific SE: Director/PDMR Shareholding
31/07	Eurofins Scientific: Director/PDMR Shareholding
29/07	Eurofins Scientific: Director/PDMR Shareholding
27/07	Eurofins: Weekly Report on Share Repurchases From 20th July to 24th July 2026
24/07	Eurofins Scientific: Director/PDMR Shareholding
24/07	Unternehmenskalender vom 27. bis 31. Juli 2026
23/07	Eurofins Scientific : BioPharma's slowdown raises questions on 2026 organic growth target
23/07	Eurofins Scientific Se Seeks Acquisitions
23/07	Tranche Update on Eurofins Scientific SE's Equity Buyback Plan announced on April 25, 2025.
23/07	Notenbanken werden von der Inflation auf dem falschen Fuß erwischt
23/07	Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth
22/07	Eurofins Scientific SE Reports Earnings Results for the Half Year Ended June 30, 2026
21/07	Eurofins Scientific: Director/PDMR Shareholding
20/07	Eurofins Scientific SE: Weekly Report on Share Repurchases from 13th July to 17th July 2026
20/07	Eurofins Scientific SE agreed to acquire Life Sciences Testing Services Business in North America from Element Materials Technology Group Limited for an enterprise value of $400 million.
20/07	Eurofins Scientific to Buy Element Materials' North American Life Sciences Testing Arm in $400 Million Deal
20/07	Eurofins Agrees to Acquire Element Materials Technology’s Life Sciences Testing Services Business in North America